SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences informs about scheme of amalgamation

04 Jan 2021 Evaluate

Gufic Biosciences has informed that in the matter of the Scheme of Amalgamation of Gufic Lifesciences (Transferor Company) with Gufic Biosciences (Transferee Company) and their respective shareholders and creditors (Scheme), the Honble National Company Law Tribunal, Ahmedabad bench vide its order dated December 31, 2020 sanctioned the said Scheme, subject to the final order of the proceedings preferred by the Transferee Company before the Honble National Company Law Tribunal, Mumbai bench. The said order is enclosed for reference. The Company shall continue to update any further progress on the matter.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×